City-based GenXAI buys app maker SoftGrid
Rakesh Agarwal, founder and executive chairman of the Jaipur-based GenXAI, said, "This strategic acquisition strengthens GenXAI's capabilities in advanced mobile application development and opens new avenues to build cutting-edge, AI-driven platforms across diverse digital ecosystems." He said the deal combines GenXAI's expertise in AI-driven solutions with Indore-based SoftGrid's legacy in custom application developmentandwebdesign.
tnn
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
2 minutes ago
- Business Standard
PropEquity sues CRE Matrix for alleged data theft, Delhi HC issues summons
Delhi-based real estate analytics firm PropEquity has filed a case against Mumbai-based CRE Matrix in the Delhi High Court, alleging data theft and infringement of its primary real estate data. PropEquity has sought a permanent injunction and damages of Rs 8 crore on account of the alleged data theft. A single-judge bench of Justice Manmeet PS Arora of the Delhi High Court issued summons to Bhugol Analytics Private Limited (trading as CRE Matrix), its directors and some employees, in an order dated July 24, released on Wednesday. The court granted time to the defendants to file their written statements and posted the matter for hearing on September 19. PropEquity, operated by PE Analytics Limited, alleged glaring similarities and almost identical figures in the primary residential data segment reported by CRE Matrix in its 'India Housing Report' published in May 2025. The firm also said CRE Matrix was not operating in the domain of primary residential data during 2021–24, the period for which the figures were released in its May 2025 report. It added that CRE Matrix acted by unethically soliciting the plaintiff's former employees, who had held important positions but resigned, violating non-compete clauses and joining the rival company. 'They colluded with the defendant and compromised the proprietary primary residential data of the plaintiff,' PropEquity said in its plea before the Delhi High Court. The firm added that it has also filed police complaints with the cyber crime branch in Gurugram, and the police has initiated an investigation.
Time of India
an hour ago
- Time of India
Natco Pharma sues Novo Nordisk in generic drug push
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel MUMBAI: Hyderabad-based Natco Pharma has sued Danish drugmaker Novo Nordisk , maker of blockbuster weight-loss drug Wegovy (semaglutide), claiming its version of the drug does not infringe upon the device or process patent technology owned by the multinational company. The case came up for hearing in Delhi High Court on Wednesday."The court has directed the parties to engage in a 'pre-litigation mediation', an attempt to bury the dispute through mutual settlement before the case can be heard on deeper nuances such as non-infringement of patents," a senior lawyer well-versed with the case told ET on condition of lawyers representing Natco Pharma informed the court that over the past few months it had approached Novo Nordisk to communicate on its non-infringing patents but received no response, said people familiar with the matter."A clear communication from the innovator may trigger a generic launch of the drug in India, sinking the prospects for Wegovy's sales and so that may be seen as a delaying tactic," said an expert, who did not wish to be Nordisk launched Wegovy in India in June, trailing its global rival Eli Lilly , which launched its patented brand Mounjaro (tirzepatide) in March. Recently, Mounjaro was launched in the easy-to-use pen device form, an improvement over its earlier versions of injectable Pharma did not comment on the development, while Novo Nordisk did not respond to queries sent by development comes months after Novo Nordisk in May sued Dr Reddy's Labs and OneSource, a contract manufacturing company, in Delhi High Court alleging infringement of its valid patents. The Danish company also claimed that the two companies were importing large quantities of the semaglutide raw material to make and export the the court called upon Novo Nordisk to submit the evidence since there was no substantive proof to back such claims. Earlier that month, Dr Reddy's Labs had filed a lawsuit for revocation of Novo Nordisk's patent for semaglutide in India is set to expire in March next year, potentially opening the floodgates for at least seven companies to launch their versions. This is expected to result in the prices plummeting at least 80% from the present levels of '17,000-26,000 per market for obesity drugs in India is expected to rapidly expand to '8,000 crore by 2030 from '700 crore at present, fuelled by aggressive marketing for such drugs and a faster adoption by doctors and patients.
Time of India
an hour ago
- Time of India
Top microfinance companies speed up bad loan write-offs to balance books
Kolkata: Leading microfinance companies are making balance sheet cleansing a priority in a bid to show a healthier portfolio amid the uptrend in bad loans . Listed entities such as CreditAccess Grameen , Fusion Finance and Muthoot Microfin went for early bad loan write-offs in the June quarter, in continuation of the strategy adopted since December last year. Fusion has gone a step further. The Gurugram-based lender has revised its write-off policy. Fusion chief executive officer Sanjay Garyali said the company has decided to strike off stressed loans from its balance sheet after 180 days of default from the June quarter, as a rule, moving away from the previous practice of write-off after 240 days of defaults. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Villas For Sale in Dubai Might Surprise You Villas In Dubai | Search Ads Get Rates Undo "In the March quarter, we did an accelerated write-off after 180 DPD (days past due). In the June quarter, we have done the same. But it's no more an accelerated write-off. We have taken it as a policy change," he told ET. Loans are marked as non-performing assets (NPAs) when borrowers fail to pay interest or principal for more than 90 days. Live Events Some microfinance companies write off loans after 240 days of default as a rule, while some even do it after a year of classifying them as non-performing. Any write-off before those datelines is termed "accelerated". Muthoot Microfin, which normally writes off accounts which remain NPA for more than 365 days, did accelerated write-offs for loans in Karnataka as early as 120 days past due (DPD), as these accounts showed no signs of repayment, chief executive Sadaf Sayeed told ET. Faster write-offs helped these companies report an improved gross non-performing assets ratio in the June quarter. For Fusion, ₹486-crore write-off in the first quarter of the fiscal helped its gross NPA improve to 5.4% at the end of June from 7.92% three months prior to that. CreditAccess Grameen's GNPA stood at 4.70% compared with 4.76% over the same period. Muthoot Microfin's GNPA stood at 4.85% against 4.84%. "An accelerated write-off journey, which commenced in Q3 FY25, is steadily driving us towards balance sheet normalisation," CreditAccess Grameen chief executive officer Ganesh Narayanan said in an analysts call on July 22.
